Organooxygen compounds
c1ccncc1 | 25g | 703124911](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502694895.jpg-250.jpg)
eMolecules 27854-88-2 | (R)-(+)-1-(4-Pyridyl)ethanol | Combi-Blocks, Inc. | MFCD00077865 | 123.155 | C7H9NO | 98.000 | C[C@@H](O)c1ccncc1 | 25g | 703124911
(R)-(+)-1-(4-Pyridyl)ethanol | Combi-Blocks, Inc. | 27854-88-2 | MFCD00077865 | 123.155 | C7H9NO | 98.000 | C[C@@H](O)c1ccncc1 | 25g | 703124911
eMolecules 24424-99-5 | Di-tert-butyl pyrocarbonate | Chem-Impex | MFCD00008805 | 218.249 | C10H18O5 | 99.000 | CC(C)(C)OC(=O)OC(=O)OC(C)(C)C | 10kg | 342448878
Di-tert-butyl pyrocarbonate | Chem-Impex | 24424-99-5 | MFCD00008805 | 218.249 | C10H18O5 | 99.000 | CC(C)(C)OC(=O)OC(=O)OC(C)(C)C | 10kg | 342448878
C(=O)NCCCO | 25g | 823749174](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502694318.jpg-250.jpg)
eMolecules 81-13-0 | (R)-2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide | Oakwood Chemical205.254 | C9H19NO4 | 98.000 | CC(C)(CO)[C@@H](O)C(=O)NCCCO | 25g | 823749174
(R)-2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide | Oakwood Chemical | 81-13-0205.254 | C9H19NO4 | 98.000 | CC(C)(CO)[C@@H](O)C(=O)NCCCO | 25g | 823749174
eMolecules 59247-47-1 | tert-butyl 4-bromobenzoate | Pharmablock | MFCD00093266 | 257.127 | C11H13BrO2 | 97.000 | CC(C)(C)OC(=O)c1ccc(Br)cc1 | 2.5g | 686930767
tert-butyl 4-bromobenzoate | Pharmablock | 59247-47-1 | MFCD00093266 | 257.127 | C11H13BrO2 | 97.000 | CC(C)(C)OC(=O)c1ccc(Br)cc1 | 2.5g | 686930767
Medchemexpress LLC 35-azido-3,6,9,12,15,18,21,24,27,30,33-undecaoxapentatriacontan-1-ol | 1821464-55-4 | MFCD13184946 | 99.8% | C24H49N3O12 | 10MG
Azide-PEG12-alcohol is a polyethylene glycol (PEG)-based linker bearing a terminal azide and hydroxyl group. It is intended for use in bioconjugation and PROTAC synthesis, enabling efficient attachment to alkyne-containing partners via click chemistry (CuAAC and SPAAC).
- High purity (≈99.8%) for reliable coupling reactions.
- Long PEG12 spacer increases solubility and flexibility in aqueous systems.
- Terminal azide functionality enables CuAAC and SPAAC click reactions.
- Available in small-scale quantities suitable for research applications.
- Stable under recommended storage conditions for extended shelf life.
Medchemexpress LLC Oxyfedrine hydrochloride | 16777-42-7 | 99.9% | 349.85 | C19H24ClNO3 | 10 MG
Oxyfedrine hydrochloride is a vasodilator and an orally active β-adrenoreceptor agonist commonly used in research to investigate cardiovascular function and adrenergic signaling. The compound is supplied as a high-purity hydrochloride salt in small-scale research quantities suitable for biochemical and pharmacological studies.
- High purity suitable for research use.
- Orally active β-adrenoreceptor agonist.
- Available in multiple small-scale package sizes, including 10 mg.
- Stable storage at 4°C in a sealed container away from moisture and light.
- Recommended solvent storage: -80°C for long-term, -20°C for short-term.
- Molecular formula C19H24ClNO3; molecular weight 349.85.
Medchemexpress LLC 1-Piperazinebutanol, α-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-, hydrochloride (1:1) | 105565-55-7 | 98.0% | 384.85 | 50 MG
BMY-14802 hydrochloride is a potent agonist of 5-HT1A and adrenergic α1 receptors, known for its antipsychotic effects.
- Appearance: white to off-white solid.
- Storage: -20°C, sealed storage, away from moisture. In solvent: -80°C, 6 months; -20°C, 1 month.
- ¹H NMR spectrum consistent with structure.
- MS consistent with structure.
- Product tested and complies with given specifications.
Medchemexpress LLC Naluzotan hydrochloride | 740873-82-9 | 99.6% | 487.10 g/mol | C23H39ClN4O3S | 10 MG
Naluzotan hydrochloride is the hydrochloride salt of a potent, selective amidosulfonamide 5-HT1A receptor agonist used in preclinical research. It is supplied as a solid research chemical with characterized purity and analytical data, intended for laboratory use only.
- High purity (99.6%) suitable for research applications.
- Potent, selective 5-HT1A receptor agonist (IC50 ≈ 20 nM; Ki ≈ 5.1 nM).
- Weak hERG K+ channel blocker (IC50 ≈ 3,800 nM), relevant for cardiac safety studies.
- Solid form; molecular weight 487.10 g/mol; formula C23H39ClN4O3S.
- Supplied in a 10 mg research pack and for research use only.
Medchemexpress LLC Noscapine (hydrochloride) | 912-60-7 | 99.9% | 449.88 | 1 G
Noscapine (hydrochloride) is an orally active phthalideisoquinoline alkaloid with potent antitussive properties. It activates sigma opioid receptors and acts as a non-competitive Bradykinin inhibitor. This compound also disrupts microtubule dynamics, induces mitotic arrest and apoptosis.
- Orally active phthalideisoquinoline alkaloid
- Potent antitussive properties
- Activates sigma opioid receptors and acts as a non-competitive Bradykinin inhibitor
- Disrupts microtubule dynamics, induces mitotic arrest and apoptosis
- Exhibits anticancer, neuroprotective, and anti-inflammatory activities
- Can cross the blood-brain barrier
eMolecules 485-47-2 | NINHYDRIN | AstaTech | MFCD00003791 | 178.143 | C9H6O4 | 95.000 | OC1(O)C(=O)c2ccccc2C1=O | 25g | 392639080
NINHYDRIN | AstaTech | 485-47-2 | MFCD00003791 | 178.143 | C9H6O4 | 95.000 | OC1(O)C(=O)c2ccccc2C1=O | 25g | 392639080
eMolecules 29671-92-9 | Chloroformamidine hydrochloride | Ochem Incorporation | MFCD00035527 | 114.960 | CH4Cl2N2 | 98.000 | Cl.NC(Cl)=N | 5g | 773154939
Chloroformamidine hydrochloride | Ochem Incorporation | 29671-92-9 | MFCD00035527 | 114.960 | CH4Cl2N2 | 98.000 | Cl.NC(Cl)=N | 5g | 773154939
Medchemexpress LLC Ravidasvir hydrochloride | 1303533-81-4 | 99.9% | 835.82 g·mol⁻1 | C42H52Cl2N8O6 | 100MG
Ravidasvir hydrochloride is a research-grade, pan-genotypic inhibitor of hepatitis C virus (HCV) nonstructural protein 5A (NS5A), supplied as a white to off-white solid and used in antiviral in vitro and preclinical studies.
- Pan-genotypic NS5A inhibitor with low-nanomolar EC50 against multiple HCV genotypes.
- High purity: 99.9% (reported by supplier).
- Molecular weight: 835.82 g·mol⁻1; formula C42H52Cl2N8O6.
- Appearance: white to off-white solid, suitable for analytical and biological assays.
- Storage: store sealed at 4°C; in solvent, -80°C for up to 6 months or -20°C for 1 month.
- Intended for research use only; not for human or clinical use.
Medchemexpress LLC Nordoxepin hydrochloride | 2887-91-4 | 99.9% | 301.81 | C18H20ClNO | 5 MG
Nordoxepin hydrochloride is the major metabolite of the tricyclic antidepressant doxepin, provided as a research-grade chemical standard for analytical and laboratory applications. This compound is intended for non-clinical research use only.
- Major metabolite of doxepin, useful as an analytical standard.
- Purity 99.9%.
- Molecular formula C18H20ClNO and molecular weight 301.81.
- White to off-white solid appearance.
- Available in small solid quantities suitable for analytical work.
- Store sealed at 4°C; solutions are stable at -80°C for long-term storage.
Medchemexpress LLC Amiloride hydrochloride | 2016-88-8 | MFCD00211292 | 99.8% | 266.09 g/mol | C6H9Cl2N7O | 10 MG
Amiloride hydrochloride is the analytical reference standard of amiloride intended for research and analytical applications. It functions as an inhibitor of epithelial sodium channels (ENaC) and urokinase-type plasminogen activator receptor (uPA), and blocks polycystin-2 (PC2/TRPP2) channels.
- High purity analytical standard (99.8%).
- Suitable for assay development, calibration, and method validation.
- Available in small reference quantities for laboratory use, such as 10 mg.
- Solid powder form, stable under recommended storage conditions.
Medchemexpress LLC AMXI-5001 hydrochloride | 98.1% | C25H21ClFN5O3 | 1 ML
AMXI-5001 hydrochloride is a potent, orally active, and dual PARP1/2 and microtubule polymerization inhibitor. It shows selective antitumor cytotoxicity across a wide range of human cancer cells with significantly lower IC50s compared to existing clinical PARP1/2 inhibitors, and can induce complete regression of established tumors, including very large ones.
- Potent and orally active
- Dual PARP1/2 and microtubule polymerization inhibitor
- Selective antitumor cytotoxicity across a wide range of human cancer cells
- Significantly lower IC50s compared to existing clinical PARP1/2 inhibitors
- Induces complete regression of established tumors